Börse Express - GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202
^Allschwil, Switzerland - June 23, 2023
Stay updated with breaking news from Breaking Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
^Allschwil, Switzerland - June 23, 2023
Heart Rhythm 2023, the society's 44th annual meeting, takes place May 19-21, in New Orleans
In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year, registry data show. Pulsed field ablation (PFA) is a novel AF ablation modality that has demonstrated preferential tissue ablation with no esophageal damage in early clinical trials, Vivek Y. Reddy, MD, director of
In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.“After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” Nicolas Derval, MD, head of
The novel ANTWERP score demonstrated good predictive value in identifying patients whose heart failure symptoms would improve after ablation for atrial fibrillation, a speaker reported.The score utilized readily available clinical values including QRS width, known etiology, AF subtype and atrial dilation to identify those who may experience improved left ventricular ejection fraction after AF